Dyadic International logo

Dyadic International Share Price Today

(NASDAQ: DYAI)

Dyadic International share price is $1.45 & ₹126.11 as on 6 Mar 2025, 2.30 'hrs' IST

$1.45

▲

0.04

(2.84%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Dyadic International share price in Dollar and Rupees. Guide to invest in Dyadic International stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Dyadic International, along with analyst recommendations, forecasts, and comprehensive financials.

Dyadic International share price movements

  • Today's Low: $1.37
    Today's High: $1.46

    Day's Volatility :6.15%

  • 52 Weeks Low: $0.93
    52 Weeks High: $2.67

    52 Weeks Volatility :65.33%

Dyadic International (DYAI) Returns

PeriodDyadic International IncIndex (Russel 2000)
3 Months
-5.37%
0.0%
6 Months
11.02%
0.0%
1 Year
1.44%
0.0%
3 Years
-59.6%
-11.6%

Dyadic International (DYAI) Key Statistics

in dollars & INR

Previous Close
$1.41
Open
$1.41
Today's High
$1.4598
Today's Low
$1.37
Market Capitalization
$33.6M
Today's Volume
$15.6K
52 Week High
$2.67
52 Week Low
$0.9257
Revenue TTM
$1.8M
Earnings Per Share (EPS)
$-0.27
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-127.38%

How to invest in Dyadic International Stock (DYAI) from India?

It is very easy for Indian residents to invest directly in Dyadic International from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Dyadic International stock in both Indian Rupees (INR) and US Dollars (USD). Search for Dyadic International or DYAI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Dyadic International or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Dyadic International shares which would translate to 0.600 fractional shares of Dyadic International as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Dyadic International, in just a few clicks!

Returns in Dyadic International (DYAI) for Indian investors in Rupees

The Dyadic International stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Dyadic International investment value today

Current value as on today

₹1,09,279

Returns

₹9,279

(+9.28%)

Returns from Dyadic International Stock

₹4,317 (+4.32%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Dyadic International (DYAI)

31%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Dyadic International Stock from India on INDmoney has increased by 31% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Dyadic International

    Analyst Recommendation on Dyadic International

    Buy

      85%Buy

      14%Hold

      0%Sell

    Based on 7 Wall street analysts offering stock ratings for Dyadic International(by analysts ranked 0 to 5 stars)

    Based on 7 analyst
    • Current
    • 1M Ago
    • 3M Ago
    Buy
    6
    6
    6
    Hold
    1
    1
    1
    Sell
    0
    0
    0

    Analyst Forecast on Dyadic International Stock (DYAI)

    What analysts predicted

    Upside of 313.79%

    Target:

    $6.00

    Current:

    $1.45

    Insights on Dyadic International Stock (Ticker Symbol: DYAI)

    • Price Movement

      In the last 7 days, DYAI stock has moved up by 4.4%

    • Increasing Revenue

      Revenue is up for the last 3 quarters, 334.61K → 1.95M (in $), with an average increase of 46.8% per quarter

    • Increasing Net Profit

      Netprofit is up for the last 2 quarters, -2.04M → -203.46K (in $), with an average increase of 905.2% per quarter

    • DYAI vs ALNY (1 yr)

      In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 62.3%

    • DYAI vs VRTX (3 yr)

      In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 109.7%

    • Price to Sales

      ForDYAI every $1 of sales, investors are willing to pay $22.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

    DYAI Dyadic International Financials in INR & Dollars

    FY18Y/Y Change
    Revenue
    $1.3M
    ↑ 70.81%
    Net Income
    $-5.7M
    ↑ 166.49%
    Net Profit Margin
    -439.36%
    ↓ 157.75%
    FY19Y/Y Change
    Revenue
    $1.7M
    ↑ 29.77%
    Net Income
    $-8.3M
    ↑ 45.96%
    Net Profit Margin
    -494.21%
    ↓ 54.85%
    FY20Y/Y Change
    Revenue
    $1.6M
    ↓ 4.71%
    Net Income
    $-9.3M
    ↑ 12.24%
    Net Profit Margin
    -582.13%
    ↓ 87.92%
    FY21Y/Y Change
    Revenue
    $2.4M
    ↑ 50.06%
    Net Income
    $-12.9M
    ↑ 38.57%
    Net Profit Margin
    -537.54%
    ↑ 44.59%
    FY22Y/Y Change
    Revenue
    $2.9M
    ↑ 21.9%
    Net Income
    $-9.4M
    ↓ 27.48%
    Net Profit Margin
    -319.79%
    ↑ 217.75%
    FY23Y/Y Change
    Revenue
    $2.9M
    ↓ 1.07%
    Net Income
    $-6.8M
    ↓ 27.48%
    Net Profit Margin
    -234.42%
    ↑ 85.37%
    Q2 FY23Q/Q Change
    Revenue
    $837.2K
    ↓ 14.41%
    Net Income
    $-2.2M
    ↓ 1664.58%
    Net Profit Margin
    -257.17%
    ↓ 271.24%
    Q3 FY23Q/Q Change
    Revenue
    $397.1K
    ↓ 52.57%
    Net Income
    $-1.6M
    ↓ 25.02%
    Net Profit Margin
    -406.55%
    ↓ 149.38%
    Q4 FY23Q/Q Change
    Revenue
    $686.5K
    ↑ 72.9%
    Net Income
    $-2.1M
    ↑ 28.34%
    Net Profit Margin
    -301.78%
    ↑ 104.77%
    Q1 FY24Q/Q Change
    Revenue
    $334.6K
    ↓ 51.26%
    Net Income
    $-2.0M
    ↓ 3.0%
    Net Profit Margin
    -600.57%
    ↓ 298.79%
    Q2 FY24Q/Q Change
    Revenue
    $385.9K
    ↑ 15.32%
    Net Income
    $-2.0M
    ↑ 1.77%
    Net Profit Margin
    -529.99%
    ↑ 70.58%
    Q3 FY24Q/Q Change
    Revenue
    $2.0M
    ↑ 407.26%
    Net Income
    $-203.5K
    ↓ 90.05%
    Net Profit Margin
    -10.39%
    ↑ 519.6%
    FY18Y/Y Change
    Profit
    $268.2K
    ↑ 242.83%
    FY19Y/Y Change
    Profit
    $221.4K
    ↓ 17.45%
    FY20Y/Y Change
    Profit
    $177.0K
    ↓ 20.05%
    FY21Y/Y Change
    Profit
    $459.4K
    ↑ 159.56%
    FY22Y/Y Change
    Profit
    $807.1K
    ↑ 75.69%
    FY23Y/Y Change
    Profit
    $923.0K
    ↑ 14.35%
    Q2 FY23Q/Q Change
    Profit
    $44.2K
    ↓ 82.39%
    Q3 FY23Q/Q Change
    Profit
    $291.2K
    ↑ 558.58%
    Q4 FY23Q/Q Change
    Profit
    $336.4K
    ↑ 15.53%
    Q1 FY24Q/Q Change
    Profit
    $190.7K
    ↓ 43.33%
    Q2 FY24Q/Q Change
    Profit
    $83.9K
    ↓ 55.97%
    Q3 FY24Q/Q Change
    Profit
    $1.6M
    ↑ 1760.38%
    FY18Y/Y Change
    Operating Cash Flow
    $-4.4M
    ↑ 69.1%
    Investing Cash Flow
    $3.3M
    ↓ 509.85%
    Financing Cash Flow
    $-2.3M
    ↓ 63.04%
    FY19Y/Y Change
    Operating Cash Flow
    $-5.8M
    ↑ 31.21%
    Investing Cash Flow
    $7.7M
    ↑ 131.57%
    Financing Cash Flow
    $550.2K
    ↓ 123.93%
    FY20Y/Y Change
    Operating Cash Flow
    $-6.6M
    ↑ 13.69%
    Investing Cash Flow
    $22.1M
    ↑ 187.02%
    Financing Cash Flow
    $255.5K
    ↓ 53.57%
    FY21Y/Y Change
    Operating Cash Flow
    $-11.3M
    ↑ 71.53%
    Investing Cash Flow
    $5.2M
    ↓ 76.4%
    Financing Cash Flow
    $1.2M
    ↑ 381.49%
    FY22Y/Y Change
    Operating Cash Flow
    $-8.1M
    ↓ 28.32%
    Investing Cash Flow
    $-2.4M
    ↓ 145.37%
    Financing Cash Flow
    $543.6K
    ↓ 55.81%
    Q2 FY23Q/Q Change
    Operating Cash Flow
    $-1.7M
    ↓ 24.34%
    Investing Cash Flow
    $1.1M
    ↓ 59.49%
    Financing Cash Flow
    $0.0
    -

    Dyadic International Technicals Summary

    Sell

    Neutral

    Buy

    Dyadic International is currently in a neutral trading position according to technical analysis indicators.

    Dyadic International (DYAI) Vs Peers

    Company Name1 Month6 Month1 Year3 Years5 Years
    Dyadic International Inc logo
    Dyadic International Inc
    -3.42%
    11.02%
    1.44%
    -59.6%
    -71.34%
    Regeneron Pharmaceuticals, Inc. logo
    Regeneron Pharmaceuticals, Inc.
    1.3%
    -41.29%
    -30.51%
    9.2%
    42.38%
    Beone Medicines Ltd logo
    Beone Medicines Ltd
    15.19%
    34.31%
    61.3%
    43.16%
    68.1%
    Vertex Pharmaceuticals Incorporated logo
    Vertex Pharmaceuticals Incorporated
    3.37%
    3.77%
    18.06%
    106.43%
    121.36%
    Alnylam Pharmaceuticals, Inc. logo
    Alnylam Pharmaceuticals, Inc.
    -11.52%
    -3.4%
    62.32%
    49.04%
    120.93%
    Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
    Dyadic International Inc logo
    Dyadic International Inc
    NA
    NA
    0.0
    -0.28
    -1.27
    -0.46
    NA
    0.2
    Regeneron Pharmaceuticals, Inc. logo
    Regeneron Pharmaceuticals, Inc.
    17.85
    17.85
    1.03
    43.09
    0.16
    0.07
    0.01
    273.57
    Beone Medicines Ltd logo
    Beone Medicines Ltd
    NA
    NA
    NA
    1.43
    -0.19
    -0.06
    NA
    31.22
    Vertex Pharmaceuticals Incorporated logo
    Vertex Pharmaceuticals Incorporated
    32.84
    NA
    1.33
    18.07
    -0.03
    0.13
    NA
    63.87
    Alnylam Pharmaceuticals, Inc. logo
    Alnylam Pharmaceuticals, Inc.
    NA
    NA
    -0.49
    0.57
    -15.01
    -0.03
    NA
    0.52
    Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
    Dyadic International Inc logo
    Dyadic International Inc
    Buy
    $33.6M
    -71.34%
    NA
    0.0%
    Regeneron Pharmaceuticals, Inc. logo
    Regeneron Pharmaceuticals, Inc.
    Buy
    $74.9B
    42.38%
    17.85
    31.07%
    Beone Medicines Ltd logo
    Beone Medicines Ltd
    NA
    $28.5B
    68.1%
    NA
    -16.92%
    Vertex Pharmaceuticals Incorporated logo
    Vertex Pharmaceuticals Incorporated
    Buy
    $124.1B
    121.36%
    32.84
    -4.86%
    Alnylam Pharmaceuticals, Inc. logo
    Alnylam Pharmaceuticals, Inc.
    Buy
    $31.5B
    120.93%
    NA
    -12.37%

    About Dyadic International

    Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health. The company offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial to demonstrate the safety in humans of a protein produced using the C1 platform. It has also developed the Dapibus thermophilic, a filamentous fungal-based microbial protein production platform to enable the development and large-scale manufacture of cost-effective proteins, metabolites, and other biologic products for use in non-pharmaceutical applications, including food, nutrition, and wellness. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; license agreement with South Africa's Rubic One Health; Joint Development Agreement with a Global Food Ingredient Company; and sub-license agreement with Abic Biological Laboratories Ltd., Alphazyme, LLC, and Abic Biological Laboratories Ltd. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
    Organization
    Dyadic International
    Employees
    7
    CEO
    Mr. Mark A. Emalfarb
    Industry
    Biotechnology

    Management People of Dyadic International

    NameTitle
    Mr. Mark A. Emalfarb
    Founder, CEO, President & Director
    Mr. Joseph P. Hazelton
    Chief Operating Officer
    Mr. Doug Pace B.A.
    Executive Vice President of Business Development
    Ms. Ana Gómez Rodriguez
    Secretary of the Board

    Important FAQs about investing in DYAI Stock from India :

    What is Dyadic International share price today?

    Dyadic International share price today stands at $1.45, Open: $1.41 ; Previous Close: $1.41 ; High: $1.46 ; Low: $1.37 ; 52 Week High: $2.67 ; 52 Week Low: $0.93.

    The stock opens at $1.41, after a previous close of $1.41. The stock reached a daily high of $1.46 and a low of $1.37, with a 52-week high of $2.67 and a 52-week low of $0.93.

    Can Indians buy Dyadic International shares?

    Yes, Indians can invest in the Dyadic International (DYAI) from India.

    With INDmoney, you can buy Dyadic International at 0 brokerage. The step-by-step process is as follows:

    • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
    • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
    • Once funds are transferred successfully, you can buy Dyadic International at zero transaction cost.

    How can I buy Dyadic International shares from India?

    It is very easy to buy Dyadic International from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

    Can Fractional shares of Dyadic International (DYAI) be purchased?

    Yes, you can buy fractional shares of Dyadic International with INDmoney app.

    What are the documents required to start investing in Dyadic International stocks?

    To start investing in Dyadic International, You will need the following documents:

    • Proof of Identification (PAN, Aadhaar etc)
    • Proof of address (Aadhaar, Voter ID etc)

    These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

    What are today’s High and Low prices of Dyadic International Stock (DYAI)?

    Today’s highest price of Dyadic International (DYAI) is $1.46.

    Today’s lowest price of Dyadic International (DYAI) is $1.37.

    What is today's market capitalisation of Dyadic International?

    Today's market capitalisation of Dyadic International DYAI is 33.6M

    What is the 52 Week High and Low Range of Dyadic International Stock (DYAI)?

    • 52 Week High

      $2.67

    • 52 Week Low

      $0.93

    What are the historical returns of Dyadic International (DYAI)?

    • 1 Month Returns

      -3.42%

    • 3 Months Returns

      11.02%

    • 1 Year Returns

      1.44%

    • 5 Years Returns

      -71.34%

    Who is the Chief Executive Officer (CEO) of Dyadic International ?

    Mr. Mark A. Emalfarb is the current Chief Executive Officer (CEO) of Dyadic International.